These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7408408)

  • 21. Absorption and metabolism of phenytoin from tablets and capsules.
    Smith TC; Kinkel A
    Clin Pharmacol Ther; 1976 Dec; 20(6):738-42. PubMed ID: 791565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diphenylhydantoin.
    Glazko AJ
    Pharmacology; 1972; 8(1):163-77. PubMed ID: 4630160
    [No Abstract]   [Full Text] [Related]  

  • 23. Interindividual variation in the extent and rate of phenytoin accumulation.
    Levine M; Orr J; Chang T
    Ther Drug Monit; 1987 Jun; 9(2):171-6. PubMed ID: 3617156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Status epilepticus in pregnancy: effect of phenytoin malabsorption on seizure control.
    Ramsay RE; Strauss RG; Wilder BJ; Willmore LJ
    Neurology; 1978 Jan; 28(1):85-9. PubMed ID: 563542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenytoin kinetics in children.
    Dodson WE
    Clin Pharmacol Ther; 1980 May; 27(5):704-7. PubMed ID: 7371368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of short- and long-term alcohol use on phenytoin kinetics in chronic alcoholics.
    Sandor P; Sellers EM; Dumbrell M; Khouw V
    Clin Pharmacol Ther; 1981 Sep; 30(3):390-7. PubMed ID: 7273603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioavailability of phenytoin acid and phenytoin sodium with enteral feedings.
    Doak KK; Haas CE; Dunnigan KJ; Reiss RA; Reiser JR; Huntress J; Altavela JL
    Pharmacotherapy; 1998; 18(3):637-45. PubMed ID: 9620116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenytoin prodrugs V: In vivo evaluation of some water-soluble phenytoin prodrugs in dogs.
    Varia SA; Stella VJ
    J Pharm Sci; 1984 Aug; 73(8):1080-7. PubMed ID: 6548519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aqueous solubility and dissolution rate does not adequately predict in vivo performance: a probe utilizing some N-acyloxymethyl phenytoin prodrugs.
    Stella VJ; Martodihardjo S; Rao VM
    J Pharm Sci; 1999 Aug; 88(8):775-9. PubMed ID: 10430541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo absorption of phenytoin from rat small intestine and its inhibition by phlorizin.
    Johansson O; Lindberg T; Melander A
    Acta Pharmacol Toxicol (Copenh); 1979 Oct; 45(4):265-71. PubMed ID: 525357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of food on the absorption of phenytoin in man.
    Melander A; Brante G; Johansson O; Lindberg T; Wåhlin-Boll E
    Eur J Clin Pharmacol; 1979 May; 15(4):269-74. PubMed ID: 477711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relative bioavailability of orally administered fosphenytoin sodium injection compared with phenytoin sodium injection in healthy volunteers.
    Kaucher KA; Acquisto NM; Rao GG; Kaufman DC; Huntress JD; Forrest A; Haas CE
    Pharmacotherapy; 2015 May; 35(5):482-8. PubMed ID: 26011141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction of absorption of digoxin, phenytoin and aspirin by activated charcoal in man.
    Neuvonen PJ; Elfving SM; Elonen E
    Eur J Clin Pharmacol; 1978 May; 13(3):213-8. PubMed ID: 668776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advocating single-dose phenytoin loading.
    Horton MW; Godley PJ
    Ann Emerg Med; 1988 Mar; 17(3):295-6. PubMed ID: 3345027
    [No Abstract]   [Full Text] [Related]  

  • 35. Bioavailability of ACC-9653 (phenytoin prodrug).
    Browne TR; Davoudi H; Donn KH; Dougherty CL; Dukes GE; Evans B; Evans JE; Jamerson B; Kres J; McEntegart CM
    Epilepsia; 1989; 30 Suppl 2():S27-32. PubMed ID: 2670536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic interaction between intravenous phenytoin and amiodarone in healthy volunteers.
    Nolan PE; Marcus FI; Hoyer GL; Bliss M; Gear K
    Clin Pharmacol Ther; 1989 Jul; 46(1):43-50. PubMed ID: 2743707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of sucralfate on phenytoin bioavailability.
    Hall TG; Cuddy PG; Glass CJ; Melethil S
    Drug Intell Clin Pharm; 1986; 20(7-8):607-11. PubMed ID: 3755676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioavailability of phenytoin on single and multiple oral doses of two dosage forms in normal subjects.
    Kohda Y; Nishihara K; Isozaki S; Saitoh Y; Nakagawa F; Tamura Z
    J Pharmacobiodyn; 1983 Jan; 6(1):46-55. PubMed ID: 6854522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenytoin tolerance tests.
    Handley AJ
    Br Med J; 1970 Jul; 3(5716):203-4. PubMed ID: 5448782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of bioavailability on the calculated Michaelis-Menten parameters of phenytoin in children.
    Koren G; Brand N; MacLeod SM
    Ther Drug Monit; 1984; 6(1):11-4. PubMed ID: 6710554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.